Tag: peripheral nerve stimulation
Nalu Medical presents long-term, holistic outcomes with PNS system at NANS...
Nalu Medical presented interim data from the “landmark” COMFORT randomised controlled trial (RCT)—indicating long-term and holistic pain management outcomes with its peripheral nerve stimulation...
SPR Therapeutics announces multiple first-time data presentations set for NANS 2024
SPR Therapeutics has announced that it is set to be featured prominently at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las...
Neuralace announces US FDA clearance for Axon therapy ahead of NANS...
Neuralace Medical has announced the US Food and Drug Administration (FDA) clearance of its “groundbreaking” Axon therapy for the treatment of chronic painful diabetic...
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
Nalu Medical announces first enrolment in peripheral nerve stimulation RCT
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS)...
New study shows benefits of BioWave’s peripheral nerve stimulation in chronic...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral...
SPR Therapeutics debuts occipital nerve stimulation data at ASRA 2022
At the 21st annual American Society of Regional Anesthesia (ASRA) pain medicine meeting (17–19 November 2022, Orlando, USA), SPR Therapeutics is highlighting five new data sets demonstrating...
Stimwave launches FREEDOM series with trial evaluating PNS in chronic knee...
Stimwave Technologies has announced the launch of its level-one FREEDOM clinical trial series—which consists of multicentre, prospective, randomised trials that monitor chronic pain patients’...
SPR Therapeutics announces expanded FDA clearance for SPRINT peripheral nerve stimulation...
SPR Therapeutics has obtained clearance from the US Food and Drug Administration (FDA) of a broader indication for the usage of its SPRINT peripheral...
Study finds significant reduction in pain with high-frequency 10kHz peripheral nerve...
A randomised controlled trial (RCT) of peripheral nerve stimulation (PNS) at 10kHz frequency demonstrates a significant reduction in pain scores for patients suffering from...
First use of SPRINT endura peripheral nerve stimulation system to treat...
SPR Therapeutics has announced that Marc Huntoon, director of pain management at the Neuroscience, Orthopaedic and Wellness Center, VCU Medical Center, was the first...
SPR Therapeutics awarded US$10M to develop its SPRINT peripheral nerve stimulation...
SPR Therapeutics has been awarded two new grants and one new contract from the US Department of Defense totalling US$10M to further develop its...
